The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In ...

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

As for what type of educational support they’re looking for, the most prevalent ask among HCPs was for clinical trial ...

What's more, both FDA Commissioner Martin Makary, M.D., and longtime FDA oncology chief Richard Pazdur, M.D., have a new ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

On a mission to expand its recently approved Tryngolza beyond the rare genetic disorder familial chylomicronemia syndrome ...

Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...

Given a list of 40 drugmakers, the respondents rated ViiV most highly in terms of corporate reputation, followed by ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...